Literature DB >> 30879854

The Use of Extracorporeal Membrane Oxygenation in Life-Threatening Foreign Body Aspiration: Case Series, Review of Extracorporeal Life Support Organization Registry Data, and Systematic Literature Review.

Pilar Anton-Martin1, Pallav Bhattarai1, Peter Rycus2, Lakshmi Raman1, Renee Potera1.   

Abstract

BACKGROUND: Foreign body aspiration (FBA) is a common cause of morbidity and mortality in children < 3 years of age. Guidelines recommend performing a bronchoscopy in any suspected or confirmed FBA. Extracorporeal membrane oxygenation (ECMO) can be used as a rescue mode of support in children with life-threatening FBA for stabilization before, during, and after removal. CASE REPORT: We present a series of children with life-threatening FBA who were placed on ECMO for stabilization before or after FB removal and a review of the literature and the Extracorporeal Life Support Organization database. Foreign bodies were removed without complications, and all patients survived ECMO support and were promptly discharged home. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: ECMO can be safely used in the stabilization of children with life-threatening FBA before, during, and after bronchoscopic removal. ECMO should be considered in the stabilization of children presenting with FBA to facilitate removal.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Extracorporeal Life Support Organization; bronchoscopy; extracorporeal membrane oxygenation; foreign body aspiration

Mesh:

Year:  2019        PMID: 30879854     DOI: 10.1016/j.jemermed.2019.01.036

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  2 in total

1.  Acute Respiratory Distress Syndrome immediately following the removal of an aspirated foreign body.

Authors:  Ryne Simpson; Charles Myer Iv; Christopher Siracusa
Journal:  Respir Med Case Rep       Date:  2019-12-10

2.  Venovenous extra corporeal life support in an infant with foreign body aspiration: A case report.

Authors:  Ahmed S AlKhalifah; Nada A AlJassim
Journal:  Respir Med Case Rep       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.